According to the recent research, there are over 80% of people would be motivated to exercise if incentivized by crypto...


Recent Study Reveals That Crypto Motivates People to Exercise

On Friday, Prime Minister Ranil Wickremesinghe warned of a food shortage as the island nation battles a devastating economic...


Thousands queue for petrol, gas in Sri Lanka amid warnings of food shortages

ASML, a semiconductor industry and stock market giant, might have to think smaller. Or maybe bigger. Currently, it is building machines...


Computer chip giant ASML places big bets on a tiny future

Finance ministers and central bank governors of the United States, Japan, Canada, Britain, Germany, France and Italy - the G7, agreed on...


Money for Ukraine Priority in G7 Agenda; Inflation, Food a Concern

An auto safety agency in the U.S. said on Wednesday that it has opened an investigation into a fatal crash involving a Tesla...

Stock Markets

U.S. Agency opens investigation involving Tesla due to 14 Crash Deaths


13 Jan 2022

AstraZeneca Announces U.S. Decision to Purchase Extra 500,000 Evusheld Doses

AstraZeneca Announces U.S. Decision to Purchase Extra 500,000 Evusheld Doses

The Index Today

AstraZeneca on Wednesday unveiled the U.S. government’s plans to buy an extra 500,000 doses of its Evusheld which can be used to prevent COVID-19 among the public prior to exposure.

Evusheld has a demonstrated ability to protect against the Omicron variant of the coronavirus through its neutralizing property. It is has proven to be one of the most effective solutions for people with weak immune systems who might otherwise experience more difficulty in fighting the virus.

As the sole antibody therapy authorized in the country, the doses are said to arrive in the U.S. within Q1 of 2022, adding to a previous batch of 700,000 Evusheld doses.